Resistance to hydrogen peroxide associated with altered catalase mRNA stability in MCF7 breast cancer cells

Biochim Biophys Acta. 1989 Sep 21;1009(1):70-4. doi: 10.1016/0167-4781(89)90080-8.

Abstract

We have established a variant of the human breast cancer cell line MCF7, designated MCF7/H2O2, which is 5-fold resistant to H2O2 by clonogenic assay. The specific activity of the H2O2 disposal enzyme catalase was elevated 3-fold in MCF7/H2O2; activities of other antioxidant enzymes, including glutathione peroxidase and superoxide dismutase, were not increased. The steady-state level of catalase mRNA was only slightly elevated (approx. 1.6-fold) in MCF7/H2O2 cells; however, degradation of catalase mRNA was markedly retarded in MCF-7/H2O2 compared to MCF-7 (82% of catalase mRNA remained 24 h after inhibition of RNA synthesis by actinomycin D in MCF-7/H2O2 vs. 32% in MCF7). The degradation rates of superoxide dismutase mRNA and 28 S ribosomal RNA were not reduced in MCF-7/H2O2; however, the rate of degradation of another mRNA species, beta-actin, was also significantly decreased. These data suggest that resistance to H2O2 in MCF7/H2O2 cells is mediated by elevated catalase activity which can be explained by stabilization of certain mRNA species, including catalase mRNA.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / genetics
  • Breast Neoplasms / enzymology*
  • Catalase / genetics*
  • Catalase / metabolism
  • Dactinomycin / pharmacology
  • Drug Resistance
  • Glutathione Peroxidase / genetics
  • Glutathione Peroxidase / metabolism
  • Half-Life
  • Humans
  • Hydrogen Peroxide / pharmacology*
  • RNA, Messenger / metabolism*
  • Superoxide Dismutase / genetics
  • Superoxide Dismutase / metabolism
  • Tumor Cells, Cultured

Substances

  • Actins
  • RNA, Messenger
  • Dactinomycin
  • Hydrogen Peroxide
  • Catalase
  • Glutathione Peroxidase
  • Superoxide Dismutase